<html><head></head><body><h1>ACD Solution Modified</h1><p class="drug-subtitle"><b>Generic Name:</b> anhydrous citric acid solution<br/>
<b>Dosage Form:</b> intravenous solution<br/></p><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><p class="First">Per your order, we have compounded ACD Solution Modified as a  solution of 10 mL in a 100 mL vial.  The characteristics of this compounded preparation are as follows</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Dosage and Administration</li>
</ul><h2>ACD Solution Modified Description</h2><p class="First">Each 100 mL vial contains 80 mg citric acid, 224 mg sodium citrate anhydrous, and 120 mg dextrose anhydrous in a sterile, non-pyrogenic solution of 10 mL. The pH of the solution has been adjusted to be between 4.5 to 5.5</p><h2>ACD Solution Modified - Clinical Pharmacology</h2><p class="First">In vitro, citrate ions combine with ionic calcium in the blood and the resulting</p><p>lack of ionic calcium prevents coagulation. Blood that has been treated with citrate anticoagulants is nontoxic to the body when injected in small amounts intravenously. After injection, citrate ions are rapidly removed from the blood by the liver, polymerized into glucose, and then metabolized in the usual manner</p><h2>Indications and Usage for ACD Solution Modified</h2><p class="First">ACD Solution Modified is to be used in the labeling of red blood cells for intravenous administration with Cr-51 Sodium Chromate.</p><h2>Contraindications</h2><p class="First">There are no known contraindications.</p><h2>ACD Solution Modified Dosage and Administration</h2><p class="First"><span class="Bold">Red Blood Cell Labeling Procedure</span></p><p class="First">depend on the intended use of the labeled red blood cells.</p><h3>Storage and Handling</h3><p class="First">Store the product at room temperature</p><h2>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</h2><p class="First"><span class="Bold">Figure 1</span></p><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>